Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125023) titled 'A Clinical Study on the Efficacy and Safety of Adebrelimab Combined with Interventional Therapy in Patients with Pancreatic Cancer Liver Metastases' on May 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Condition:
Pancreatic cancer with liver metastases
Intervention:
Trial group:Atezolizumab combined with interventional therapy: 1. Transarterial infusion chemotherapy (Oxaliplatin 60 mg/m^2 + Liposomal Irinotecan 50 mg/m^2 + LV 400 mg/m^2 + 5-FU 2400 mg/m^2, Day 1, q4...